-
1
Persistence of immunity and impact of third dose of inactivated COVID-19 vaccine against emerging variants
Published 2022-07-01Get full text
Article -
2
-
3
-
4
-
5
-
6
Evidence of Extended Thermo-Stability of Typhoid Polysaccharide Conjugate Vaccines
Published 2021-08-01“…Studies performed in parallel by the vaccine manufacturer, Bharat Biotech International Limited, and an independent national control laboratory (NIBSC) monitored its stability-indicating parameters: <i>O</i>-acetylation of the Vi polysaccharide, integrity of the polysaccharide–protein conjugate, and its molecular size and pH. …”
Get full text
Article -
7
Sero-efficacy of Vi-polysaccharide tetanus-toxoid typhoid conjugate vaccine (Typbar-TCV)
Published 2018“…<strong>Methods</strong> Data were obtained from a previously published phase 3 randomised controlled trial comparing Vi-polysaccharide tetanus-toxoid conjugate vaccine (Typbar-TCV; Bharat Biotech Intl Ltd, India): (Vi-TT) with Vi-polysaccharide (Typbar; Bharat Biotech Intl Ltd, India): (Vi-PS) in participants aged 2- 45 years. …”
Journal article -
8
-
9
Protective efficacy of COVAXIN® against Delta and Omicron variants in hamster model
Published 2022-10-01Get full text
Article -
10
Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases
Published 2021-04-01“…India’s drug regulator has approved restricted emergency use of Covishield (the name employed in India for the Oxford-AstraZeneca vaccine) and Covaxin, the home-grown vaccine produced by Bharat Biotech. Indian manufacturers have stated that they have the capacity to meet the country’s future needs for COVID-19 vaccines. …”
Get full text
Article -
11
-
12
Ethnological aspects of COVID-19
Published 2022-12-01“…Some of the recently approved vaccines are developed by Pfizer and Moderna, Johnson and Johnson, Gam-COVID-vac (Sputnik V), Bharat Biotech (covaxin) andOxford-AstraZeneca vaccines (covishield) (Badenet al., 2021). …”
Get full text
Article -
13
Product review of the rotavirus vaccines ROTASIIL, ROTAVAC, and Rotavin-M1
Published 2021-04-01“…In addition to the globally available, WHO-prequalified ROTARIX (GSK) and RotaTeq (Merck), several new rotavirus vaccines have attained national licensure – ROTAVAC (Bharat Biotech) and ROTASIIL (Serum Institute of India), licensed and manufactured in India and now WHO-prequalified, and Rotavin-M1 (PolyVac), licensed and manufactured in Vietnam. …”
Get full text
Article -
14
Spectrum of mucocutaneous reactions to COVID-19 vaccination: A report from a web-based study from India
Published 2022-01-01“…Methods: An online questionnaire-based study was performed among the recipients of COVID-19 vaccines Results: Majority (73.6%) of the responders had received the Covishield vaccine (AstraZeneca-Oxford), while 26.4% had been vaccinated with Covaxin (Bharat Biotech-ICMR). One or more post-vaccination mucocutaneous effects were experienced in 87 (19.6%) participants. …”
Get full text
Article -
15
Safety and Adverse Events Related to Inactivated COVID-19 Vaccines and Novavax; a Systematic Review
Published 2022-07-01“…Conclusion: This systematic review indicates that inactivated COVID-19 vaccines, including Sinovac, Sinopharm, and Bharat Biotech, as well as the protein subunit vaccines (Novavax) can be considered as safe choices due to having milder side effects and fewer severe life-threatening adverse events. …”
Get full text
Article -
16
Study on adverse event following COVID 19 vaccination at tertiary care hospital, Karwars
Published 2023-01-01“…Covaxin, an inactivated vaccine developed and manufactured by Bharat Biotech and Covishield, the Oxford AstraZeneca vaccine is being manufactured locally by Serum Institute of India. …”
Get full text
Article -
17
Impact and cost-effectiveness of rotavirus vaccination in Niger: a modelling study evaluating alternative rotavirus vaccines
Published 2022-10-01“…Local data were collected as part of a clinical trial taking place in the Madarounfa district, Maradi region, Niger.Participants The study models impact of infants vaccination on rotavirus gastroenteritis in children under 5 years of age.Interventions We compared the use of ROTARIX (GlaxoSmithKline, Belgium), ROTAVAC (Bharat Biotech, India) and ROTASIIL (Serum Institute, India) to no vaccination and to each other over a 10-year period starting in 2021.Results We estimated that ROTARIX, ROTAVAC and ROTASIIL would each prevent 13 million cases and 20 000 deaths of children under 5 years over a 10-year period in Niger. …”
Get full text
Article -
18
VACCINATION COVERAGE AMONG HEALTH CARE WORKER IN A GOVERNMENT CANCER HOSPITAL IN EASTERN UTTAR PRADESH IN INDIA
Published 2023-08-01“…Two vaccines used for this drive were Oxford-AstraZeneca's Covishield and Bharat Biotech's Covaxin. Our institute an upcoming state of art cancer centre in eastern Uttar Pradesh and acted as a centre for vaccination. …”
Get full text
Article -
19
A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E’s Vi-capsular polysaccharide-CRM197 co...
Published 2022-11-01“…We conducted a multicenter, single-blind, randomized, Phase 2/3 study to assess the immunogenicity and safety of Biological E’s Typhoid Vi-CRM197 conjugate vaccine (TyphiBEVTM) compared to Vi-TT conjugate vaccine manufactured by Bharat Biotech International Limited (Typbar-TCV; licensed comparator) in healthy infants, children, and adults from India. …”
Get full text
Article -
20
Human health implications of emerging diseases and the current situation in India's vaccine industry
Published 2023-01-01“…India's vaccine sector has emerged, among the oriented leaders of the Bharat Biotech, Serum Institute of India, Panacea Biotech and Biological E. …”
Get full text
Article